Delivery Order SPE2DB20D1100-SPE2DB24FB1Q3

Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $29K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $14,914.29 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TREMFYA 100 MG/ML INJECTORML pharmaceutical products. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a $27,203.88 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of TREMFYA 100 MG/ML INJECTORML pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order, valued at $21,165.74, is for the supply of TREMFYA 100 MG/ML syringes. AmerisourceBergen Drug Corp is the prime contractor and has received this delivery order under a $999,999,999.00 indefinite delivery contract with DLA to provide pharmaceutical products and medical supplies to support...
This is a $8,493.51 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the provision of TREMFYA 100 MG/ML INJECTORML. The contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,125.47, is for the supply of TREMFYA 100 MG/ML ONE-PRESSML, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2025 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of TREMFYA 100 MG/ML SYRINGEML. This $8,266.87 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp, as the prime contractor, has previously received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $25,314.25, is a Firm Fixed Price Delivery Order for the supply of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of the pharmaceutical product TREMFYA 100 MG/ML INJECTORML, with a ceiling value of $23,613.24 and a performance period through April 9, 2024. AmerisourceBergen Drug Corp serves as a prime contractor for DLA Troop Support Medical, providing a wide range of pharmaceutical and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $22,606.12, is for the supply of TREMFYA 100 MG/ML syringes. It is a firm fixed-price contract with an ultimate completion date of October 9, 2024. The contract does not have a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by various federal...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, to provide TREMFYA 100 MG/ML INJECTORML, a specialty pharmaceutical product. The $11,599.85 firm fixed price contract has a completion date of July 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide range of pharmaceutical...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB1Q3
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $29,153.94 firm fixed price delivery order for the pharmaceutical product TREMFYA 100 MG/ML INJECTORML. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense military treatment programs and facilities worldwide. The award does not contain a set-aside designation. Amerisourcebergen Corporation, through its Cencora Inc. division, is the parent company of the prime contractor Amerisourcebergen Drug Corp.

Generated 7/8/24, 9:25 AM